Adaptive immune responses against parvovirus B19 in patients with myocardial disease

Journal of Clinical Virology

Volumn 44, Issue 1, 2009, Pages 27-32

  Lindner, Juha ^a   Noutsias, Michel ^b   Lassner, Dirk ^c   Wenzel, Jürgen ^a   Schultheiss, Heinz Peter ^b   Kuehl, Uwe ^b   Modrow, Susanne ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c Institute of Cardiac Diagnostics and Therapy (IKDT)   (Germany)

Author keywords

Cardiomyopathy; Cellular immune response; Humoral immune response; Myocarditis; Parvovirus B19

Indexed keywords

VIRUS DNA;

ADAPTIVE IMMUNITY; ADULT; AGED; ARTICLE; CELL SPECIFICITY; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HEART MUSCLE BIOPSY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MYOCARDIAL DISEASE; MYOCARDITIS; PARVOVIRUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SERODIAGNOSIS; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE ACTIVATION; VIREMIA; VIRUS PATHOGENESIS; WESTERN BLOTTING;

ADULT; AGED; ANTIBODIES, VIRAL; BLOTTING, WESTERN; CARDIOMYOPATHIES; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; VIRAL LOAD;

EID: 57749088520     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2008.09.007     Document Type: Article

References (44)

1. Bowles N.E., Richardson P.J., Olsen E.G., and Archard L.C. Detection of Coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet 1 May (8490) (1986) 1120-1123
2. Dettmeyer R., Kandolf R., Baasner A., Banaschak S., Eis-Hubinger A.M., and Madea B. Fatal parvovirus B19 myocarditis in an 8-year-old boy. J Forensic Sci 48 January (1) (2003) 183-186
3. Kuhl U., Pauschinger M., Seeberg B., Lassner D., Noutsias M., Poller W., et al. Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation 112 September (13) (2005) 1965-1970
4. Kuhl U., Pauschinger M., Schwimmbeck P.L., Seeberg B., Lober C., Noutsias M., et al. Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation 107 June (22) (2003) 2793-2798
5. D'Ambrosio A., Patti G., Manzoli A., Sinagra G., Di Lenarda A., Silvestri F., et al. The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review. Heart 85 May (5) (2001) 499-504
6. Noutsias M., Pauschinger M., Poller W.C., Schultheiss H.P., and Kuhl U. Immunomodulatory treatment strategies in inflammatory cardiomyopathy: current status and future perspectives. Expert Rev Cardiovasc Ther 2 January (1) (2004) 37-51
7. Mahrholdt H., Goedecke C., Wagner A., Meinhardt G., Athanasiadis A., Vogelsberg H., et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 109 March (10) (2004) 1250-1258
8. Cassinotti P., Burtonboy G., Fopp M., and Siegl G. Evidence for persistence of human parvovirus B19 DNA in bone marrow. J Med Virol 53 November (3) (1997) 229-232
9. Soderlund M., von Essen R., Haapasaari J., Kiistala U., Kiviluoto O., and Hedman K. Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy. Lancet 349 April (9058) (1997) 1063-1065
10. Eis-Hubinger A.M., Reber U., Abdul-Nour T., Glatzel U., Lauschke H., and Putz U. Evidence for persistence of parvovirus B19 DNA in livers of adults. J Med Virol 65 October (2) (2001) 395-401
11. Norja P., Hokynar K., Aaltonen L.M., Chen R., Ranki A., Partio E.K., et al. Bioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue. Proc Natl Acad Sci USA 103 May (19) (2006) 7450-7453
12. Kuhl U., Lassner D., Pauschinger M., Gross U.M., Seeberg B., Noutsias M., et al. Prevalence of erythrovirus genotypes in the myocardium of patients with dilated cardiomyopathy. J Med Virol 80 July (7) (2008) 1243-1251
13. Bultmann B.D., Klingel K., Nabauer M., Wallwiener D., and Kandolf R. High prevalence of viral genomes and inflammation in peripartum cardiomyopathy. Am J Obstet Gynecol 193 August (2) (2005) 363-365
14. Tschope C., Bock C.T., Kasner M., Noutsias M., Westermann D., Schwimmbeck P.L., et al. High prevalence of cardiac parvovirus B19 infection in patients with isolated left ventricular diastolic dysfunction. Circulation 111 February (7) (2005) 879-886
15. Mahrholdt H., Wagner A., Deluigi C.C., Kispert E., Hager S., Meinhardt G., et al. Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation 114 October (15) (2006) 1581-1590
16. Caforio A.L., Calabrese F., Angelini A., Tona F., Vinci A., Bottaro S., et al. A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis. Eur Heart J 28 June (11) (2007) 1326-1333
17. Kuethe F., Sigusch H.H., Hilbig K., Tresselt C., Gluck B., Egerer R., et al. Detection of viral genome in the myocardium: lack of prognostic and functional relevance in patients with acute dilated cardiomyopathy. Am Heart J 153 May (5) (2007) 850-858
18. Rohrer C., Gartner B., Sauerbrei A., Bohm S., Hottentrager B., Raab U., et al. Seroprevalence of parvovirus B19 in the German population. Epidemiol Infect (January 2008) 1-12
19. Anderson M.J., Lewis E., Kidd I.M., Hall S.M., and Cohen B.J. An outbreak of erythema infectiosum associated with human parvovirus infection. J Hyg (Lond) 93 August (1) (1984) 85-93
20. Young N.S., and Brown K.E. Parvovirus B19. N Engl J Med 350 February (6) (2004) 586-597
21. Soderlund M., Brown C.S., Spaan W.J., Hedman L., and Hedman K. Epitope type-specific IgG responses to capsid proteins VP1 and VP2 of human parvovirus B19. J Infect Dis 172 December (6) (1995) 1431-1436
22. Hemauer A., Gigler A., Searle K., Beckenlehner K., Raab U., Broliden K., et al. Seroprevalence of parvovirus B19 NS1-specific IgG in B19-infected and uninfected individuals and in infected pregnant women. J Med Virol 60 January (1) (2000) 48-55
23. von Poblotzki A., Hemauer A., Gigler A., Puchhammer-Stockl E., Heinz F.X., Pont J., et al. Antibodies to the nonstructural protein of parvovirus B19 in persistently infected patients: implications for pathogenesis. J Infect Dis 172 November (5) (1995) 1356-1359
24. Lindner J, Zehentmeier S, Franssila R, Schroder J, Barabas S, Deml L, et al. CD4+ T helper cell responses against human bocavirus VP2 virus-like particles in healthy adults. J Infect Dis 2008; (October (2)), in press.
25. Franssila R., Auramo J., Modrow S., Mobs M., Oker-Blom C., Kapyla P., et al. T helper cell-mediated interferon-gamma expression after human parvovirus B19 infection: persisting VP2-specific and transient VP1u-specific activity. Clin Exp Immunol 142 October (1) (2005) 53-61
26. Lindner J., Barabas S., Saar K., Altmann D., Pfister A., Fleck M., et al. CD4(+) T-cell responses against the VP1-unique region in individuals with recent and persistent parvovirus B19 infection. J Vet Med B: Infect Dis Vet Publ Health 52 September (7-8) (2005) 356-361
27. Tolfvenstam T., Oxenius A., Price D.A., Shacklett B.L., Spiegel H.M., Hedman K., et al. Direct ex vivo measurement of CD8(+) T-lymphocyte responses to human parvovirus B19. J Virol 75 January (1) (2001) 540-543
28. Escher F, Modrow S, Sabi T, Kuhl U, Lassner D, Schultheiss HP, et al. Parvovirus B19 profiles in patients presenting with acute myocarditis and chronic dilated cardiomyopathy. Med Sci Monit, 2008; in press.
29. Noutsias M., Seeberg B., Schultheiss H.P., and Kuhl U. Expression of cell adhesion molecules in dilated cardiomyopathy: evidence for endothelial activation in inflammatory cardiomyopathy. Circulation 99 April (16) (1999) 2124-2131
30. Angelini A., Calzolari V., Calabrese F., Boffa G.M., Maddalena F., Chioin R., et al. Myocarditis mimicking acute myocardial infarction: role of endomyocardial biopsy in the differential diagnosis. Heart 84 September (3) (2000) 245-250
31. Wojnicz R., Nowalany-Kozielska E., Wojciechowska C., Glanowska G., Wilczewski P., Niklewski T., et al. Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results. Circulation 104 July (1) (2001) 39-45
32. Kuhl U., Pauschinger M., Bock T., Klingel K., Schwimmbeck C.P., Seeberg B., et al. Parvovirus B19 infection mimicking acute myocardial infarction. Circulation 108 August (8) (2003) 945-950
33. Liefeldt L., Plentz A., Klempa B., Kershaw O., Endres A.S., Raab U., et al. Recurrent high level parvovirus B19/genotype 2 viremia in a renal transplant recipient analyzed by real-time PCR for simultaneous detection of genotypes 1 to 3. J Med Virol 75 January (1) (2005) 161-169
34. Knoll A., Louwen F., Kochanowski B., Plentz A., Stussel J., Beckenlehner K., et al. Parvovirus B19 infection in pregnancy: quantitative viral DNA analysis using a kinetic fluorescence detection system (TaqMan PCR). J Med Virol 67 June (2) (2002) 259-266
35. Aretz H.T. Myocarditis: the Dallas criteria. Hum Pathol 18 June (6) (1987) 619-624
36. Noutsias M., Pauschinger M., Ostermann K., Escher F., Blohm J.H., Schultheiss H.P., et al. Digital image analysis system for the quantification of infiltrates and cell adhesion molecules in inflammatory cardiomyopathy. Med Sci Monit 8 (2002) MT59-MT71
37. Pfrepper K.I., Enders M., and Motz M. Human parvovirus B19 serology and avidity using a combination of recombinant antigens enables a differentiated picture of the current state of infection. J Vet Med B: Infect Dis Vet Publ Health 52 September (7-8) (2005) 362-365
38. Kaufmann B., Baxa U., Chipman P.R., Rossmann M.G., Modrow S., and Seckler R. Parvovirus B19 does not bind to membrane-associated globoside in vitro. Virology 332 February (1) (2005) 189-198
39. Wild J., Bojak A., Deml L., and Wagner R. Influence of polypeptide size and intracellular sorting on the induction of epitope-specific CTL responses by DNA vaccines in a mouse model. Vaccine 22 April (13-14) (2004) 1732-1743
40. Donoso M.O., Meyer R., Prosch S., Nitsche A., Leitmeyer K., Kallies R., et al. High prevalence of cardiotropic viruses in myocardial tissue from explanted hearts of heart transplant recipients and heart donors: a 3-year retrospective study from a German patients' pool. J Heart Lung Transplant 24 October (10) (2005) 1632-1638
41. Jonetzko P., Graziadei I., Nachbaur K., Vogel W., Pankuweit S., Zwick R., et al. Fatal course of parvovirus B19-associated myocarditis in a female liver transplant recipient. Liver Transplant 11 April (4) (2005) 463-466
42. Gutersohn A., Zimmermann U., Bartel T., and Erbel R. A rare case of acute 'infective' myocardial infarction triggered by acute parvovirus B19 myocarditis. Nat Clin Pract Cardiovasc Med 2 March (3) (2005) 167-171
43. Lamparter S., Schoppet M., Pankuweit S., and Maisch B. Acute parvovirus B19 infection associated with myocarditis in an immunocompetent adult. Hum Pathol 34 March (7) (2003) 725-728
44. Enders G., Dotsch J., Bauer J., Nutzenadel W., Hengel H., Haffner D., et al. Life-threatening parvovirus B19-associated myocarditis and cardiac transplantation as possible therapy: two case reports. Clin Infect Dis 26 February (2) (1998) 355-358